News
Question: I am a woman with a BMI of 31 and have recently been put on statins for high cholesterol. I have also been told ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in China. Nowadays, China is emerging as important innovator ...
GLP-1 drugs like Ozempic® and Zepbound®, have gained significant attention in recent years for treating both diabetes and ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...
A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others.
Subscribe to UCSF NewsA UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?
At first, Chinese pharmaceutical companies rushed to make similar versions of blockbuster weight-loss drugs, such as Wegovy and Ozempic, that have taken ... fatty liver disease, chronic kidney disease ...
One of the main researchers, Professor Tore Bengtsson from Stockholm University, said this could be an exciting step forward.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results